about
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generati...
Read More
1.04
0.12
(13.04%)
158.7K
XNAS Volume
XNAS 04 May, 2026 4:02 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Valion Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..